Q2 2014 Earnings Conference Call
August 6, 2014 10:00 AM ET
Martin S. Gerstl – Chairman of the Board of Directors
Anat Cohen-Dayag – President & Cheif Executive Officer
Avihai Shen –...
Compugen Ltd. shares rose almost 4% in premarket trade Monday, after the company said it has achieved an initial milestone in a cancer immunotherapy partnership with Bayer Healthcare, a unit of Bayer AG . The company said the milestone relates to...
Analysts at JMP Securities initiated coverage on shares of Compugen (NASDAQ: CGEN) with a “market outperform” rating. The target price for Compugen is set to $14. Compugen's shares closed at $9.06 yesterday.
Wedbush initiated coverage on...
Compugen Ltd. (NASDAQ: CGEN) disclosed today positive experimental results for
CGEN-15052, a novel immune checkpoint candidate for cancer immunotherapy,
which in several experimental settings demonstrated robust inhibition of T
Compugen Ltd. (CGEN)
Q1 2014 Results Earnings Conference Call
May 19, 2014 10:00 AM ET
Martin Gerstl - Chairman of the Board
Dr. Anat Cohen-Dayag - President and CEO
Avihai Shen - Interim Chief Financial Officer
NEW YORK (TheStreet) -- Compugen was given a "buy" rating with a price target of $17 by analysts at Jefferies Group. The Israel-based drug discovery company has a 52-week low of $4.56 and a 52 week high of $14.32. Shares opened at $11.45...
Horizon Pharma (NASDAQ: HZNP) surged 20.91% to $17.75 in the pre-market session after the company announced its plans to acquire privately held Vidara Therapeutics International for around $660 million.
Exact Sciences (NASDAQ: EXAS) surged...
TORONTO, ONTARIO -- (Marketwired) -- 03/11/14 -- Compugen Inc. is pleased to announce that as part of Microsoft Canada's comprehensive assessment of its partners' capabilities, Compugen will continue to retain the Licensing Solutions Partner (LSP)...
Oops! Unable to complete your request. Please refresh your browser.
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article.